FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the composition of racecadotril with immediate and prolonged release, a single dose or a two-chamber package containing this composition, as well as to the use and method of treating a subject suffering from the gastrointestinal tract disease or disorder.
EFFECT: invention can help patients suffering from the gastrointestinal tract disease or disorder.
15 cl, 4 ex, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
NEW IMPROVED COMPOSITION CONTAINING AT LEAST ONE CADOTRIL | 2017 |
|
RU2751772C2 |
LIQUID ORAL PHARMACEUTICAL DOSAGE FORM CONTAINING HISTAMINE H2-RECEPTOR ANTAGONIST AND ANTACID | 2017 |
|
RU2761346C2 |
LIQUID ORAL PHARMACEUTICAL DOSAGE FORM | 2019 |
|
RU2810115C2 |
RACECADOTRIL LIPID COMPOSITIONS | 2014 |
|
RU2662069C2 |
LIQUID ORAL PHARMACEUTICAL DOSAGE FORM | 2019 |
|
RU2783413C2 |
LIPID COMPOSITIONS OF RACECADOTRIL | 2013 |
|
RU2632441C2 |
COMPOSITIONS OF LONG-TERM ACTION BASED ON KETOPROFEN | 2014 |
|
RU2646829C1 |
CLEANSING COMPOSITIONS | 2015 |
|
RU2680846C2 |
USE OF ORGANIC EXTRACT OF CITRUS FRUITS WITH HIGH ANTIMICROBIAL ACTIVITY AS SYSTEM OF PRESERVING AGENTS IN LIQUIDS, EMULSIONS, SUSPENSIONS, CREAMS AND ANTACIDS | 2016 |
|
RU2714879C2 |
USE OF ORGANIC CITRUS EXTRACT WITH HIGH ANTIMICROBIAL CAPACITY AND XYLITOL AS PRESERVATIVE SYSTEM IN LIQUIDS, EMULSIONS, SUSPENSIONS, CREAMS AND ANTACIDS | 2016 |
|
RU2715906C2 |
Authors
Dates
2021-04-02—Published
2017-08-21—Filed